why choose us

First received: June 13, 2023

Clinical Trial: A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Institute of Hematology & Blood Diseases Hospital

Brief Summary: The study is to evaluate the safety and efficacy of COVID-19 convalescent plasma (CCP) transfusion to prevent COVID-19 in adult recipients following hematopoietic stem cell transplantation.72 patients will be randomized in a 1:1 ratio to receive either CCR (36 patients) or not (36 patients).Patients in the CCP group will receive 200 ml of CCP at +14 days, +28 days, +2 months, and +3 months following hematopoietic stem cell transplantation.Patients in the control group would be routinely given oral ursodeoxycholic…

Read more